Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sleep Number Corporation SEC filings document its personalized sleep-products business, capital structure and public-company governance. Form 8-K disclosures cover operating results, Regulation FD investor presentations, amendments to its credit agreement, covenant and liquidity terms, financing arrangements, officer appointments, board changes and compensatory arrangements.
The company’s proxy materials describe director matters, executive compensation, equity awards and shareholder voting items. Together, the filings provide formal records for Sleep Number’s direct-to-consumer retail model, product and marketing strategy, debt obligations, internal reporting roles and governance practices.
Sleep Number Corporation entered into a new debtor-in-possession credit agreement that provides up to $260 million in Chapter 11 financing. This includes up to $65 million in new superpriority term loans and up to $195 million of existing secured debt converted into roll-up loans.
The Bankruptcy Court has entered an interim order approving the facility, with a final hearing scheduled for July 9, 2026. The DIP and roll-up loans mature on September 16, 2026 and bear interest at SOFR + 8.00% or a base rate plus 7.00%. The loans are secured by first-priority, priming, and junior liens on various collateral and are subject to strict covenants, case milestones, and budget variance tests. The company discloses significant risks related to its Chapter 11 process, including the likely cancellation of its common shares and uncertainty around completing a Section 363 sale or reorganization.
Sleep Number Corp executive Christopher D. Krusmark reported an insider stock sale. As EVP, Retail & People Officer, he executed an open-market sale of 3,130.1645 shares of Common Stock at a price of $0.6600 per share through an indirect 401(k) holding.
Following these transactions, Krusmark reports 50,241.0000 shares of Sleep Number Common Stock held directly. The indirect 401(k) position now shows zero shares remaining after the sale.
Sleep Number Corp EVP Christopher D. Krusmark reported a disposition of 30,720 shares of common stock to the issuer at a weighted average price of $0.3699 per share. The filing notes these shares were transacted in multiple trades between $0.36 and $0.38 per share.
After this issuer disposition, Krusmark beneficially owns 50,241 shares of Sleep Number common stock directly. He also holds an additional 3,130.1645 shares indirectly through a 401(k) plan, reflecting his remaining equity exposure following the reported transactions.
Sleep Number Corp EVP Chief Legal & Risk Officer Samuel R. Hellfeld reported an insider transaction involving the company’s common stock. He disposed of 40,000 shares in a transaction coded as a disposition to the issuer at a weighted average price of $0.3900 per share, with individual trades between $0.3732 and $0.4100. Following the transaction, he directly owns 75,772 shares of Sleep Number common stock and indirectly holds 7,964.04 shares through a 401(k) plan.
Sleep Number Corp Principal Accounting Officer Kelly F. Baker reported a disposition of company shares back to the issuer. On June 12, 2026, Baker returned 614 shares of Common Stock to the company at a value of $0.3962 per share. Following this transaction, Baker directly holds 9,745 shares of Sleep Number Common Stock, indicating a routine adjustment of a relatively small portion of her equity position.
Sleep Number Corp executive Amber Minson, EVP and Chief Marketing Officer, reported a disposition of 4,293 shares of common stock back to the issuer. The shares were transferred at 0.405 per share. After this transaction, she directly holds 47,965 shares of Sleep Number common stock.
Sleep Number Corp executive Melissa Barra reported a disposition of Common Stock. On June 12, 2026, she disposed of 81,512 shares at a weighted average price of $0.3721 per share, with individual transaction prices between $0.3456 and $0.3918. Following this transaction, she directly holds 86,678 shares of Sleep Number Common Stock.
Sleep Number Corp director Stephen E. Macadam reported a disposition of 97,272 shares of common stock at a weighted average price of $0.4355 per share. The shares were sold in multiple transactions at prices between $0.4100 and $0.4699. After this transaction, he directly owned 30,300 shares and indirectly held 137 shares through an IRA.
Sleep Number Corp senior vice president and Chief Supply Chain officer Tanya C. Skogerboe reported an insider transaction involving company common stock. She disposed of 21,566 shares in a disposition to the issuer at $0.3800 per share, which is a return of shares to the company rather than an open-market sale. After this transaction, she directly holds 45,086.0000 common shares. A separate entry updates an indirect holding of 2,517.4642 common shares held through a 401k plan, with no buy or sell direction indicated for that 401k position.